CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2012.12.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology
Cancer ResearchOncology
2019English

Coffee and Green Tea Consumption and Subsequent Risk of Acute Myeloid Leukemia and Myelodysplastic Syndromes in Japan

International Journal of Cancer
Cancer ResearchOncology
2017English

Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Effectiveness of 5-Azacytidine in Older Patients With High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia: A Retrospective Analysis of the Hellenic (Greek) MDS Study Group

Journal of Geriatric Oncology
GerontologyGeriatricsOncology
2020English

High BCAT1 Expression Mimics IDH Mutations in Acute Myeloid Leukemia

Cancer Discovery
Oncology
2017English

SALL1 Expression in Acute Myeloid Leukemia

Oncotarget
Oncology
2017English

Mixed T Lymphocyte Chimerism After Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Histopathology in the Diagnosis of High-Risk Myelodysplastic Syndromes

Journal of clinical and experimental hematopathology : JCEH
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy